Copertina

Dehydroepiandrosterone‐α‐2‐Deoxyglucoside Exhibits Enhanced Anticancer Effects in MCF‐7 Breast Cancer Cells and Inhibits Glucose‐6‐Phosphate Dehydrogenase Activity

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Hsu‐Feng Liu, Shen‐Chieh Chou, Sheng‐Cih Huang, Tzu‐Yu Huang, Po‐Yun Hsiao, Feng‐Pai Chou, Tung‐Kung Wu
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Puerarin Decreases the Expression of FUS‐Dependent MAPK4 to Inhibit the Development of Triple‐Negative Breast Cancer
di: Jian Guo, et al.
Pubblicazione: (2024)

Novel 10‐Alkoxy 1,4‐Dien‐3‐One Estranes as Multitarget Anticancer Agents Against Estrogen‐Positive Breast Cancer
di: Ivana Kuzminac, et al.
Pubblicazione: (2026)

Skullcapflavone II Suppresses Colorectal Cancer by Inhibiting the HIF ‐1α‐Glycolysis Pathway
di: Shiwei Yang, et al.
Pubblicazione: (2025)

Ferulic Acid Inhibits Partial Epithelial‐Mesenchymal Transition in Renal Tubular Epithelial Cells and Mitigates Renal Interstitial Fibrosis by Regulating the HIF‐1α/Twist Signaling Pathway
di: Lin Xu, et al.
Pubblicazione: (2025)

Multifaceted In Silico Screening Strategies Identifies Potent Inhibitors Facilitating Inhibition of ZNF726 Activity in Breast Cancer
di: Shreetama Bandyopadhayaya, et al.
Pubblicazione: (2025)

Anticancer mechanisms of β‐carbolines
di: Shivam Mishra, et al.
Pubblicazione: (2024)

Prediction of Breast Cancer Lymph Node Metastasis by a Nomogram Model Integrating Pathomics, Radiomics, and Immunoscore
di: Tian Xu, et al.
Pubblicazione: (2026)

Madecassoside Induces Apoptosis and Inhibits Migration by Regulating ROS ‐Mediated Signaling Pathways in MDA ‐ MB ‐231 Breast Cancer Cells
di: Wen‐Shuang Hou, et al.
Pubblicazione: (2025)

Stigmasterol Inhibits Glioma Metastasis and Angiogenesis by Regulating Macrophage Polarization
di: Xiangying Li, et al.
Pubblicazione: (2026)

Synthesis and SAR investigation of biphenylaminoquinoline derivatives with benzyloxy substituents as promising anticancer agents
di: Yu‐Chieh Wu, et al.
Pubblicazione: (2024)

The Potent Antioxidant 3,5‐Dihydroxy‐4‐Methoxybenzyl Alcohol Reveals Anticancer Activity by Targeting Several Signaling Pathways in Bone Metastatic Human Breast Cancer MDA‐MB‐231 Cells
di: Masayoshi Yamaguchi, et al.
Pubblicazione: (2025)

Fused and Substituted Piperazines as Anticancer Agents: A Review
di: Saumya Singh, et al.
Pubblicazione: (2025)

Icaritin Inhibits Malignant Progression and Enhances Ferroptosis and Bortezomib Sensitivity by Suppressing HSP90AA1 Expression in Multiple Myeloma
di: Lin Shi, et al.
Pubblicazione: (2026)

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Synthesis and Preliminary Anticancer Evaluation of 4‐C Derivatives of Diphyllin
di: Ruihan Zhao, et al.
Pubblicazione: (2024)

Coumarin‐Augmented Thiazole Hybrids as Dual Anticancer and Antibacterial Agents
di: Islam K. Matar, et al.
Pubblicazione: (2026)

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐f][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition
di: Balaji Dashrath Sathe, et al.
Pubblicazione: (2024)

Hepatocellular Carcinoma Cells in Humans Exhibit Resistance to Suberoylanilide Hydroxamic Acid (SAHA) Owing to the Diminished Level of Hsa‐miR‐125a‐5p
di: Shih‐Wen Kao, et al.
Pubblicazione: (2025)

Novel Synthesized Benzophenone Thiazole Hybrids Exhibited Ex Vivo and In Silico Anti‐Inflammatory Activity
di: Luiz Paulo Melchior de Oliveira Leão, et al.
Pubblicazione: (2024)

Design, Synthesis and Biological Evaluation of Aminoalkylated Paeonol Chalcone Derivatives
di: Jia‐chen Xu, et al.
Pubblicazione: (2026)

Novel Benzimidazole‐Urea Phenylalanine Hybrids as Dual‐Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation
di: Tuğçe Deniz Karaca, et al.
Pubblicazione: (2026)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2026)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
di: Vijaykumar D. Nimbarte, et al.
Pubblicazione: (2025)

Design, Synthesis, and Biological Evaluation of New Benzimidazole‐1,2,4‐Triazole Derivatives as Potential Anticancer Agents
di: Ecem Kaya‐Sezginer, et al.
Pubblicazione: (2024)

New Benzothiazole‐Thiadiazole‐Based Ketones as Potential Antiviral and Anticancer Agents: Synthesis, DFT, and Molecular Docking Studies
di: Khadra B. Alomari, et al.
Pubblicazione: (2025)

Antiproliferative Activity and Target Analysis of 18β‐Glycyrrhetinic Acid Derivatives Modified With α, β‐Unsaturated Carbonyl Groups
di: Chenmeng Xu, et al.
Pubblicazione: (2025)

1,2,3‐Triazole Tethered Spiro[Indoline‐Oxirane] Derivatives Induce Anticancer Effects in Human Hepatoma Cells
di: Shashikala Mariswamy Rajesh, et al.
Pubblicazione: (2025)

In Vitro Cytotoxicity and Mechanistic Investigation of Quinazolin‐4(1H)‐One Linked Coumarin as a Potent Anticancer Agent
di: Dinesh Singla, et al.
Pubblicazione: (2024)

Attempts to Achieve Targeted Covalent Inhibition of Hsp90 β
di: Terin D'Amico, et al.
Pubblicazione: (2026)

Design and Synthesis of Holu‐7, a Quinazolinone Derivative With an Active Stereo Geometry and Polar 2,4‐Dihydroxyphenyl Group, as a Selective Anticancer Agent
di: Kuo‐Chu Lai, et al.
Pubblicazione: (2025)

Pyrrole‐Tethered Bisbenzoxazole Derivatives: Apoptosis‐Inducing Agents Targeting Breast Cancer Cells
di: Burak Kuzu, et al.
Pubblicazione: (2025)

Unveiling the Therapeutic Potential of Paclitaxel Combinations Against Breast Carcinoma and Identification of In Vivo Biomarkers
di: Aamir Mehmood, et al.
Pubblicazione: (2024)

Exploring the Mechanism of Myrrh in the Treatment of Breast Cancer Based on Network Pharmacology and Cell Experiments
di: Wu Tao, et al.
Pubblicazione: (2024)

Design, Synthesis, Molecular Docking, ADME ‐T and In Vitro Anticancer Assessment of Phenyl‐Substituted‐Pyrimidin‐Benzenesulfonamide Derivatives as Potential BRAF V600E / WT Inhibitors
di: Ankit Kumar Singh, et al.
Pubblicazione: (2025)

Beyond ATP Synthase Inhibition: Chemical Diversification, Bioactivities, and Therapeutic Potential of Oligomycin A
di: Mohamed S. Nafie, et al.
Pubblicazione: (2025)

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
di: Yuan‐Liang Gao, et al.
Pubblicazione: (2024)

Pyrazoline–Imidazopyridine Hybrids as Beclin‐1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer
di: Rashmi Shivakumar, et al.
Pubblicazione: (2026)

Synthesis, Biological Assay, and SAR of Potential Anticancer Lipophilic Fluoroquinolones ( FQs ) and Pyridoquinoxalines ( PQs ) Conjugated to Gold Nanoparticles for Synergistic and Proapoptogenic Cytotoxicity Drug Design and Targeted Delivery
di: Alaa Tabaza, et al.
Pubblicazione: (2025)

99mTc‐HYNIC PEGylated Peptide Probe Targeting HER2‐Expression in Breast Cancer
di: Sushree Arpitabala Yadav, et al.
Pubblicazione: (2025)

From Virtual Screening to Cell Phenotype: 4‐Thiazolidone Scaffolds Targeting LOXL2 in Breast Cancer
di: Sandra Ferreira, et al.
Pubblicazione: (2026)